Genomic and gene expression signatures of radiation in medulloblastomas after low-dose irradiation in Ptch1 heterozygous mice

Carcinogenesis

Volumn 31, Issue 9, 2010, Pages 1694-1701

  Ishida, Yuka ^a,b   Takabatake, Takashi ^a   Kakinuma, Shizuko ^a   Doi, Kazutaka ^a   Yamauchi, Kazumi ^a   Kaminishi, Mutsumi ^a   Kito, Seiji ^a   Ohta, Yuki ^a,c   Amasaki, Yoshiko ^a   Moritake, Hiroyuki ^c   Kokubo, Toshiaki ^a,b   Nishimura, Mayumi ^a   Nishikawa, Tetsu ^a   Hino, Okio ^b   Shimada, Yoshiya ^a  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

^c Science Service Inc   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN PATCHED 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; CANCER RADIOTHERAPY; CHROMOSOME 13; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DEVELOPMENTAL STAGE; FEMALE; GENE; GENE DOSAGE; GENE EXPRESSION; GENE LOCUS; GENOMICS; HETEROZYGOSITY LOSS; HETEROZYGOTE; INCIDENCE; LOW ENERGY RADIATION; MALE; MEDULLOBLASTOMA; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; X IRRADIATION;

ANIMALS; COMPARATIVE GENOMIC HYBRIDIZATION; DNA, NEOPLASM; DOSE-RESPONSE RELATIONSHIP, RADIATION; GENE EXPRESSION PROFILING; GENOMICS; HETEROZYGOTE; LOSS OF HETEROZYGOSITY; MEDULLOBLASTOMA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOPLASMS, RADIATION-INDUCED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, CELL SURFACE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; X-RAYS;

EID: 77956286589     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgq145     Document Type: Article

References (47)

1. Berrington de Gonzalez, A. et al. (2009) Projected cancer risks from computed tomographic scans performed in the United States in 2007. Arch. Intern. Med., 169, 2071-2077.
2. Brenner, D.J. et al. (2007) Computed tomography-an increasing source of radiation exposure. N. Engl. J. Med., 357, 2277-2284.
3. Kleinerman, R.A. (2006) Cancer risks following diagnostic and therapeutic radiation exposure in children. Pediatr. Radiol., 36 (suppl 2), 121-125.
4. Prasad, K.N. et al. (2004) Health risks of low dose ionizing radiation in humans: a review. Exp. Biol. Med. (Maywood), 229, 378-382.
5. Smith-Bindman, R. et al. (2009) Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Arch. Intern. Med., 169, 2078-2086.
6. ICRP (2007) The 2007 Recommendations of the International Commission on Radiological Protection. ICRP publication 103. Ann. ICRP, 37, 1-332.
7. NRC (2005) Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII-Phase 2. The National Academies Press, Washington, DC.
8. Pierce, D.A. et al. (2000) Radiation-related cancer risks at low doses among atomic bomb survivors. Radiat. Res., 154, 178-186.
9. Preston, D.L. et al. (2003) Studies of mortality of atomic bomb survivors. Report 13: solid cancer and noncancer disease mortality: 1950-1997. Radiat. Res., 160, 381-407.
10. Cardis, E. et al. (2007) The 15-country collaborative study of cancer risk among radiation workers in the nuclear industry: estimates of radiationrelated cancer risks. Radiat. Res., 167, 396-416.
11. Muirhead, C.R. et al. (2009) Mortality and cancer incidence following occupational radiation exposure: third analysis of the National Registry for Radiation Workers. Br. J. Cancer, 100, 206-212.
12. Preston, D.L. et al. (2007) Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat. Res., 168, 1-64.
13. Mullenders, L. et al. (2009) Assessing cancer risks of low-dose radiation. Nat. Rev. Cancer, 9, 596-604.
14. ICRP (1998) Genetic susceptibility to cancer. ICRP publication 79. Approved by the Commission in May 1997. International Commission on Radiological Protection. Ann. ICRP, 28, 1-157.
15. Taipale, J. et al. (2001) The Hedgehog and Wnt signalling pathways in cancer. Nature, 411, 349-354.
16. Marino, S. (2005) Medulloblastoma: developmental mechanisms out of control. Trends Mol. Med., 11, 17-22.
17. Romer, J. et al. (2005) Targeting medulloblastoma: small-molecule inhibitors of the Sonic Hedgehog pathway as potential cancer therapeutics. Cancer Res., 65, 4975-4978.
18. Gorlin, R.J. (1999) Patient described by Chun et al. may not present Antley-Bixler syndrome. Am. J. Med. Genet., 83, 64.
19. Scharnagel, I.M. et al. (1949) Multiple basal cell epitheliomas in a 5 year old child. Am. J. Dis. Child., 77, 647-51.
20. Goodrich, L.V. et al. (1997) Altered neural cell fates and medulloblastoma in mouse patched mutants. Science, 277, 1109-1113.
21. Hahn, H. et al. (1998) Rhabdomyosarcomas and radiation hypersensitivity in a mouse model of Gorlin syndrome. Nat. Med., 4, 619-622.
22. Pazzaglia, S. et al. (2009) Physical, heritable and age-related factors as modifiers of radiation cancer risk in patched heterozygous mice. Int. J. Radiat. Oncol. Biol. Phys., 73, 1203-1210.
23. Pazzaglia, S. et al. (2006) Two-hit model for progression of medulloblastoma preneoplasia in Patched heterozygous mice. Oncogene, 25, 5575-5580.
24. Yang, Z.J. et al. (2008)Medulloblastoma can be initiated by deletion of Patched in lineage-restricted progenitors or stem cells. Cancer Cell, 14, 135-145.
25. Livak, K.J. et al. (2001) Analysis of relative gene expression data using realtime quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 25, 402-408.
26. Knudson, A.G. Jr. (1971) Mutation and cancer: statistical study of retinoblastoma. Proc. Natl Acad. Sci. USA, 68, 820-823.
27. Knudson, A.G. (1996) Hereditary cancer: two hits revisited. J. Cancer Res. Clin. Oncol., 122, 135-140.
28. Ciani, E. et al. (2003) Developmental expression of the cell cycle and apoptosis controlling gene, Lot1, in the rat cerebellum and in cultures of cerebellar granule cells. Brain Res. Dev. Brain Res., 142, 193-202.
29. Constam, D.B. et al. (1994) Transient production of TGF-beta 2 by postnatal cerebellar neurons and its effect on neuroblast proliferation. Eur. J. Neurosci., 6, 766-778.
30. Kho, A.T. et al. (2004) Conserved mechanisms across development and tumorigenesis revealed by a mouse development perspective of human cancers. Genes Dev., 18, 629-640.
31. Zindy, F. et al. (2007) Genetic alterations in mouse medulloblastomas and generation of tumors de novo from primary cerebellar granule neuron precursors. Cancer Res., 67, 2676-2684.
32. Frappart, P.O. et al. (2009) Recurrent genomic alterations characterize medulloblastoma arising from DNA double-strand break repair deficiency. Proc. Natl Acad. Sci. USA, 106, 1880-1885.
33. Kimmel, R.R. et al. (2006) Microarray comparative genomic hybridization reveals genome-wide patterns of DNA gains and losses in post-Chernobyl thyroid cancer. Radiat. Res., 166, 519-531.
34. Haines, J. et al. (2000) Loss of heterozygosity in spontaneous and X-rayinduced intestinal tumors arising in F1 hybrid min mice: evidence for sequential loss of APC(+) and Dpc4 in tumor development. Genes Chromosomes Cancer, 28, 387-394.
35. Mao, J.H. et al. (2005) Genomic instability in radiation-induced mouse lymphoma from p53 heterozygous mice. Oncogene, 24, 7924-7934.
36. Shimada, Y. et al. (2000) Radiation-associated loss of heterozygosity at the Zna1 (Ikaros) locus on chromosome 11 in murine thymic lymphomas. Radiat. Res., 154, 293-300.
37. Takabatake, T. et al. (2006) Array-CGH analyses of murine malignant lymphomas: genomic clues to understanding the effects of chronic exposure to low-dose-rate gamma rays on lymphomagenesis. Radiat. Res., 166, 61-72.
38. Mizuno, T. et al. (2006) Molecular basis of basal cell carcinogenesis in the atomic-bomb survivor population: p53 and PTCH gene alterations. Carcinogenesis, 27, 2286-2294.
39. Park, M.S. et al. (1995) Molecular analysis of gamma-ray-induced mutations at the hprt locus in primary human skin fibroblasts by multiplex polymerase chain reaction. Radiat. Res., 141, 11-18.
40. Ponomareva, O.N. et al. (2002) Tissue-specific deletion and discontinuous loss of heterozygosity are signatures for the mutagenic effects of ionizing radiation in solid tissues. Cancer Res., 62, 1518-1523.
41. Liang, L. et al. (2002) Radiation-induced genetic instability in vivo depends on p53 status. Mutat. Res., 502, 69-80.
42. Mao, J.H. et al. (2003) Genetic interactions between Pten and p53 in radiation-induced lymphoma development. Oncogene, 22, 8379-8385.
43. Takabatake, T. et al. (2008) Analysis of changes in DNA copy number in radiation-induced thymic lymphomas of susceptible C57BL/6, resistant C3H and hybrid F1 mice. Radiat. Res., 169, 426-436.
44. Kakinuma, S. et al. (2002) Spectrum of Zna1(Ikaros) inactivation and its association with loss of heterozygosity in radiogenic T-cell lymphomas in susceptible B6C3F1 mice. Radiat. Res., 157, 331-340.
45. Yamaguchi, Y. et al. (2010) Complicated biallelic inactivation of Pten in radiation-induced mouse thymic lymphomas. Mutat. Res., 686, 30-38.
46. Pazzaglia, S. et al. (2006) Linking DNA damage to medulloblastoma tumorigenesis in patched heterozygous knockout mice. Oncogene, 25, 1165-1173.
47. Kool, M. et al. (2008) Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features. PLoS One, 3, e3088.